Patanjali's intriguing claim is backed by trials conducted by the group on coronavirus patients. Company's chief executive officer Acharya Balkrishna, while speaking to reporters on Sunday, said the trials of their medicines showed that the COVID-19 patients recovered within 5-14 days of consuming the medicine.